Cutler Group LLC / CA - GALMED PHARMACEUTICALS LTD ownership

GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106. A total of 44 filers reported holding GALMED PHARMACEUTICALS LTD in Q4 2018. The put-call ratio across all filers is 1.21 and the average weighting 0.2%.

Quarter-by-quarter ownership
Cutler Group LLC / CA ownership history of GALMED PHARMACEUTICALS LTD
ValueSharesWeighting
Q2 2021$01,600
+128.6%
0.00%
Q1 2021$0700
-12.5%
0.00%
Q4 2020$0800
+33.3%
0.00%
Q3 2020$0600
-14.3%
0.00%
Q2 2020$0
-100.0%
700
-87.7%
0.00%
Q1 2020$1,000
-66.7%
5,700
+42.5%
0.00%
Q4 2019$3,0004,000
+3900.0%
0.00%
Q3 2019$01000.0%0.00%
Q2 2019$0
-100.0%
100
-75.0%
0.00%
Q1 2019$3,000
-96.2%
400
-96.6%
0.00%
-100.0%
Q4 2018$80,000
-7.0%
11,700
+4.5%
0.01%
+16.7%
Q3 2018$86,000
+8500.0%
11,200
+11100.0%
0.01%
Q2 2018$1,0001000.00%
Other shareholders
GALMED PHARMACEUTICALS LTD shareholders Q4 2018
NameSharesValueWeighting ↓
BVF INC/IL 1,347,755$574,8180.02%
Virtu Financial LLC 31,633$130.00%
Western Wealth Management, LLC 29,537$12,5970.00%
Belpointe Asset Management LLC 14,050$5,9920.00%
TSFG, LLC 3,000$10.00%
ZRC WEALTH MANAGEMENT, LLC 100$430.00%
Allworth Financial LP 250$1070.00%
JANE STREET GROUP, LLC 13,189$5,6250.00%
RAYMOND JAMES & ASSOCIATES 138,040$58,8740.00%
BOURGEON CAPITAL MANAGEMENT LLC 500$2140.00%
View complete list of GALMED PHARMACEUTICALS LTD shareholders